Zhou C - Search Results

1

Nivolumab Versus Docetaxel in a Predominantly Chinese Patient Population With Previously Treated Advanced NSCLC: CheckMate 078 Randomized Phase III Clinical Trial.

Wu YL, Lu S, Cheng Y, Zhou C, Wang J, Mok T, Zhang L, Tu HY, Wu L, Feng J, Zhang Y, Luft AV, Zhou J, Ma Z, Lu Y, Hu C, Shi Y, Baudelet C, Cai J, Chang J. Wu YL, et al. Among authors: zhou j, zhou c. J Thorac Oncol. 2019 May;14(5):867-875. doi: 10.1016/j.jtho.2019.01.006. Epub 2019 Jan 17. J Thorac Oncol. 2019. PMID: 30659987 Free article. Clinical Trial.

2

Clinical efficacy of erlotinib in patients previously treated for advanced non-small cell lung cancer.

Zhou S, Ren S, Yan L, Zhang L, Tang L, Zhang J, Zhou C. Zhou S, et al. Among authors: zhou c. Respirology. 2009 Jul;14(5):709-15. doi: 10.1111/j.1440-1843.2009.01564.x. Respirology. 2009. PMID: 19659649 Clinical Trial.

3

Predictive effects of ERCC1 and XRCC3 SNP on efficacy of platinum-based chemotherapy in advanced NSCLC patients.

Zhou C, Ren S, Zhou S, Zhang L, Su C, Zhang Z, Deng Q, Zhang J. Zhou C, et al. Among authors: zhou s. Jpn J Clin Oncol. 2010 Oct;40(10):954-60. doi: 10.1093/jjco/hyq071. Epub 2010 May 12. Jpn J Clin Oncol. 2010. PMID: 20462983

4

High-level mRNA of excision repair cross-complementation group 1 gene is associated with poor outcome of platinum-based doublet chemotherapy of advanced nonsmall cell lung cancer patients.

Ren S, Zhou S, Zhang L, Xu J, Lv M, Zhang J, Zhou C, Zhang J. Ren S, et al. Among authors: zhou s, zhou c. Cancer Invest. 2010 Dec;28(10):1078-83. doi: 10.3109/07357901003735659. Epub 2010 May 26. Cancer Invest. 2010. PMID: 20504223 Clinical Trial.

5

Efficacy and safety of erlotinib in 1242 East/South-East Asian patients with advanced non-small cell lung cancer.

Mok T, Wu YL, Au JS, Zhou C, Zhang L, Perng RP, Park K. Mok T, et al. Among authors: zhou c. J Thorac Oncol. 2010 Oct;5(10):1609-15. doi: 10.1097/JTO.0b013e3181e15d55. J Thorac Oncol. 2010. PMID: 20808255 Free article. Clinical Trial.

6

Treatment of advanced non-small-cell lung cancer with Chinese herbal medicine by stages combined with chemotherapy.

Xu ZY, Jin CJ, Zhou CC, Wang ZQ, Zhou WD, Deng HB, Zhang M, Su W, Cai XY. Xu ZY, et al. J Cancer Res Clin Oncol. 2011 Jul;137(7):1117-22. doi: 10.1007/s00432-011-0975-3. Epub 2011 Feb 5. J Cancer Res Clin Oncol. 2011. PMID: 21298288 Clinical Trial.

7

Safety and efficacy of first-line bevacizumab with chemotherapy in Asian patients with advanced nonsquamous NSCLC: results from the phase IV MO19390 (SAiL) study.

Tsai CM, Au JS, Chang GC, Cheng AC, Zhou C, Wu YL. Tsai CM, et al. Among authors: zhou c. J Thorac Oncol. 2011 Jun;6(6):1092-7. doi: 10.1097/JTO.0b013e318216687d. J Thorac Oncol. 2011. PMID: 21512405 Free article. Clinical Trial.

8

Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy.

Ren S, Zhou S, Wu F, Zhang L, Li X, Zhang J, Xu J, Lv M, Zhang J, Zhou C. Ren S, et al. Among authors: zhou s, zhou c. Lung Cancer. 2012 Jan;75(1):102-9. doi: 10.1016/j.lungcan.2011.05.023. Epub 2011 Jun 14. Lung Cancer. 2012. PMID: 21676483

9

Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study.

Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C, Zhang S, Wang J, Zhou S, Ren S, Lu S, Zhang L, Hu C, Hu C, Luo Y, Chen L, Ye M, Huang J, Zhi X, Zhang Y, Xiu Q, Ma J, Zhang L, You C. Zhou C, et al. Among authors: zhou s. Lancet Oncol. 2011 Aug;12(8):735-42. doi: 10.1016/S1470-2045(11)70184-X. Epub 2011 Jul 23. Lancet Oncol. 2011. PMID: 21783417 Clinical Trial.

10

Epidermal growth factor receptor-tyrosine kinase inhibitor therapy is effective as first-line treatment of advanced non-small-cell lung cancer with mutated EGFR: A meta-analysis from six phase III randomized controlled trials.

Gao G, Ren S, Li A, Xu J, Xu Q, Su C, Guo J, Deng Q, Zhou C. Gao G, et al. Among authors: zhou c. Int J Cancer. 2012 Sep 1;131(5):E822-9. doi: 10.1002/ijc.27396. Epub 2012 Jan 27. Int J Cancer. 2012. PMID: 22161771

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

20,843 results

Search Page

Filters